Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

Authors: Jaspreet S. Batra, Muhammad Junaid Niaz, Young E. Whang, Arif Sheikh, Charlene Thomas, Paul J. Christos, Shankar Vallabhajosula, Yuliya Jhanwar, Ana M. Molina, David M. Nanus, Joseph R. Osborne, Neil H. Bander, Scott T. Tagawa - Urologic Oncology Seminars and Original Investigations 2020 cited by 48